This week, President Biden has directed the United States Trade Representative (“USTR”) to take further action against Chinese unfair trading practices following the release of the statutory four-year review of Section 301 tariffs against the People’s Republic of China (“PRC”). Per Biden’s direction, Ambassador Katherine Tai announced that she will be proposing modifications to existing

As the four-year review of Section 301 duties continues, the Office of the U.S. Trade Representative (USTR) stated last week that the Biden administration will be extending tariff exclusions through May 31, 2024. These exclusions, listed in the USTR’s index, were set to expire on December 31, 2023, but the administration chose to extend

The Office of the United States Trade Representative (“USTR”) announced on September 6, 2023 the further extension of 352 reinstated exclusions and 77 COVID-related exclusions from the Section 301 tariffs on imports from China. These exclusions, which cover a variety of products ranging from machinery components to medical equipment, constitute the only remaining active exclusions

This Tuesday, January 17, marked the close for the Office of the United States Trade Representative’s (USTR’s) comment period for its statutory 4-year review of tariffs imposed on Chinese goods under Section 301 of the Trade Act of 1974. To-date, the Biden Administration has retained Section 301 tariffs on over $300 billion worth of imports

On December 16th, the United States Trade Representative (“USTR”) extended 352 exclusions which exclude certain products from the additional duties caused by the Section 301 actions taken against imports from China. These exclusions were scheduled to expire on December 31, 2022 but will now extend until September 30, 2023. USTR reinstated these 352

On Wednesday, November 23, the Office of the U.S. Trade Representative (USTR) extended exclusions from Section 301 tariffs for 81 medical care products from China for a sixth time. The tariff exclusions for these products were initially granted in December 2020 and had been extended multiple times throughout the COVID-19 pandemic. The tariff exclusions for

On Tuesday (Nov. 1, 2022), the Office of the United States Trade Representative (“USTR”) released a preview of its questionnaire seeking comments on the effectiveness and impacts of the additional duties levied on Chinese-origin goods enacted under Section 301 of the Trade Act of 1974 (“Section 301 tariffs”).  The Section 301 tariffs, which commenced in

On Monday, August 1st, the Office of the U.S. Trade Representative (USTR) filed remand results with the U.S. Court of International Trade (CIT), releasing updated explanations for retaliatory tariffs on roughly $300 billion worth of Chinese goods imposed in the midst of the U.S. – China Trade War. USTR filed the remand as